Korro Bio, Inc. Common Stock — Chart, Price & News (NASDAQ:KRRO) | MetaTrader

Open full chart

Financials

Overview Estratto Conto Statistics Dividends

Quarterly Annual

Market Capitalization 113.9196 M
Employee 87
Founded 2014
CEO N/A
Website www.korrobio.com
Headquarter Delaware, United States
FIGI BBG00GFMTC38
Industry Technology

Total revenue

Net income

Basic earnings per share (Basic EPS)

Total debt

Free cash flow

Cash & equivalents

113.92 M Market capitalization

Price to earnings ratio

-4.06

Price to sales ratio

149.54

Dividends per share

—

Dividend yield %

—

Notizie

Collegium Pharmaceutical (COLL) Q4 Earnings and Revenues Miss Estimates

Clear Street alza il rating su Korro Bio per il potenziale del programma iperammonemia

Clear Street upgrades Korro Bio stock rating on hyperammonemia program potential

Strength Seen in Korro Bio, Inc. (KRRO): Can Its 13.9% Jump Turn into More Strength?

H.C. Wainwright alza il rating del titolo Korro Bio a Buy per il potenziale di un nuovo farmaco

Korro Bio stock rating upgraded by H.C. Wainwright to Buy on new drug potential

Piper Sandler alza il rating di Korro Bio a Overweight grazie al trattamento UCD

Piper Sandler upgrades Korro Bio stock rating to Overweight on UCD treatment

Chardan Capital upgrades Korro Bio stock to Buy on KRRO-121 potential

Korro Bio, Inc. (KRRO) Analyst/Investor Day - Slideshow (NASDAQ:KRRO) 2026-01-28

Raymond James riconferma il rating Market Perform per le azioni di Korro Bio

William Blair conferma il rating Market Perform sulle azioni di Korro Bio